Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:10
  • preuzimanja u poslednjih 30 dana:5

Sadržaj

članak: 4 od 6  
Back povratak na rezultate
2017, vol. 56, br. 3, str. 137-142
Demografske karakteristike bazocelularnog karcinoma - retrospektivna studija 1884 promene
aUniverzitet u Nišu, Medicinski fakultet + Klinički centar Niš, Klinika za plastičnu hirurgiju
bKlinički centar Niš, Klinika za plastičnu hirurgiju
cPharmaceutical company 'Pharma Swiss', Niš
dDental practice 'Your dentist', Aleksinac

e-adresagste66@yahoo.com
Ključne reči: bazocelularni karcinom; recidiv
Sažetak
Bazocelularni karcinom je najčešći tumor kože i čini oko 75% svih tumora kože. Brojni su etiološki faktori odgovorni za njegov nastanak, od genetskih do faktora sredine, kao što je na primer izlaganje suncu. Cilj rada bio je da prikaže demografske karakteristike i distribuciju bazocelularnog karcinoma i da proceni povezanost lokalizacije lezija sa polom, veličinom, stepenom recidiva. Retrospektivna studija obuhvatila je 1734 bolesnika sa 1884 promene, koji su lečeni na Klinici za plastičnu i rekonstruktivnu hirurgiju Kliničkog centra u Nišu od januara 2012. do decembra 2016. godine. Ispitivani su sledeći parametri: starost, pol, lokalizacija, histološki tip, margine ekscizije i stepen recidiva. Od ukupno 1884 promene, 1621 je bila primarna, a 263 su bile recidivi bazo-celularnog karcinoma. Sa visokorizičnim lokalizacijama bilo je 82,8% primarnih promena i 68,4% recidiva. U odnosu na pol, primarnih je bilo kod 56% muškaraca i 44% žena, dok su recidivi bili češći kod žena (58,2%). Što se veličine tumora tiče, 85,3% primarnih i 72,6% recidiva imali su veličinu do 2 cm u prečniku, dok je 14,7% primarnih i 27,4% recidiva bilo veće od 2 cm u prečniku. Kompletna ekscizija predstavlja osnovu hirurškog lečenja bazocelularnog karcinoma kože. Dobijeni rezultati mogu biti koristan vodič u lečenju i praćenju bazocelularnog karcinoma kože.
Reference
Ad Hoc Task Force, Connolly, S.M., Baker, D.R., Coldiron, B.M., Fazio, M.J., Storrs, P.A., i dr. (2012) AAD/ACMS/ ASDSA/ASMS2012 appropriate use criteria for mohs micrographic surgery: A report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mo. J Am Acad Dermatol, 67(4), 531-50
Bariani, R.L., Nahas, F.X., Barbosa, M.V.J., Farah, A.B., Ferreira, L.M. (2006) Basal cell carcinoma: an updated epidemiological and therapeutically profile of an urban population. Acta Cirurgica Brasileira, 21(2): 66-73
Batra, R. S. (2002) Predictors of Extensive Subclinical Spread in Nonmelanoma Skin Cancer Treated With Mohs Micrographic Surgery. Archives of Dermatology, 138(8): 1043
Chen, J.G., Fleischer, A.B., Smith, E.D., Kancler, C., Goldman, N.D., Williford, P.M., Feldman, S.R. (2001) Cost of Nonmelanoma Skin Cancer Treatment in the United States. Dermatologic Surgery, 27(12): 1035-1038
Christenson, L.J. (2005) Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years. JAMA, 294(6): 681
Cigna, E., Tarallo, M., Maruccia, M., Sorvillo, V., Pollastrini, A., Scuderi, N. (2011) Basal Cell Carcinoma: 10 Years of Experience. Journal of Skin Cancer, 2011: 1-5
Conway, R.M. (2004) Surgery for primary basal cell carcinoma including the eyelid margins with intraoperative frozen section control: comparative interventional study with a minimum clinical follow up of 5 years. British Journal of Ophthalmology, 88(2): 236-238
Diepgen, T.L., Mahler, V. (2002) The epidemiology of skin cancer. Br J Dermatol, 146 Suppl 61: 1-6
Fleischer, A.B., Feldman, S.R., Barlow, J.O., Zheng, B., Hahn, H.B., Chuang, T., Draft, K.S., Golitz, L.E., Wu, E., Katz, A.S., Maize, J.C., Knapp, T., Leshin, B. (2001) The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: Results from a multi-institutional retrospective study. Journal of the American Academy of Dermatology, 44(2): 224-230
Gulleth, Y., Goldberg, N., Silverman, R.P., Gastman, B.R. (2010) What Is the Best Surgical Margin for a Basal Cell Carcinoma: A Meta-Analysis of the Literature. Plastic and Reconstructive Surgery, 126(4): 1222-1231
Huang, C.C., Boyce, S.M. (2004) Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Seminars in Cutaneous Medicine and Surgery, 23(3): 167-173
Khandwala, M.A., Lalchan, S., Chang, B.Y. P., Habib, M., Chakrabarty, A., Cassells-Brown, A. (2005) Outcome of Periocular Basal Cell Carcinoma Managed by Overnight Paraffin Section. Orbit, 24(4): 243-247
Kyrgidis, A., Vahtsevanos, K., Tzellos, T.G., Xirou, P., Kitikidou, K., Antoniades, K., i dr. (2010) Clinical histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur J Dermatol, 20: 276-82
Luz, F.B., Ferron, C., Cardoso, G.P. (2016) Analysis of effectiveness of a surgical treatment algorithm for basal cell carcinoma. Anais Brasileiros de Dermatologia, 91(6): 726-731
Mainz, J. (2003) Defining and classifying clinical indicators for quality improvement. International Journal for Quality in Health Care, 15(6): 523-530
Mosterd, K., Krekels, G.A.M., Nieman, F.H.M., Ostertag, J.U., Essers, B.A.B., Dirksen, C.D., Steijlen, P.M., Vermeulen, A., Neumann, H.A.M., Kelleners-Smeets, N.W.J. (2008) Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncology, 9(12): 1149-1156
Nagore, E., Grau, C., Molinero, J., Fortea, J.M. (2003) Positive margins in basal cell carcinoma: Relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol, 17(2): 167-70
Pichardo-Velazquez, P., Dominguez-Cherit, J., Vega-Memije, M., Moreno-Coutino, G., Proy, H. (2004) Surgical option for nonmelanoma skin cancer. Int J Dermatol, 43(2): 148-50
Rowe, D.E., Carroll, R.J., Day, C.L. (2013) Long-Term Recurrence Rates in Previously Untreated (Primary) Basal Cell Carcinoma: Implications for Patient Follow-Up. Journal of Dermatologic Surgery and Oncology, 15(3): 315-328
Rowe, D.E., Carroll, R.J., Day, C.L. (2013) Mohs Surgery Is the Treatment of Choice for Recurrent (Previously Treated) Basal Cell Carcinoma. Journal of Dermatologic Surgery and Oncology, 15(4): 424-431
Sherry, K.R., Reid, L.A., Wilmshurst, A.D. (2010) A five year review of basal cell carcinoma excisions. Journal of Plastic, Reconstructive & Aesthetic Surgery, 63(9): 1485-1489
Telfer, N.R., Colver, G.B., Morton, C.A. (2008) Guidelines for the management of basal cell carcinoma. British journal of dermatology, 159(1): 35-48
Thomas, D.J., King, A.R., Peat, B.G. (2003) Excision Margins for Nonmelanotic Skin Cancer. Plastic and Reconstructive Surgery, 112(1): 57-63
Trakatelli, M., Ulrich, C., Marmol, V., Euvrard, S., Euvard, S., Stockfleth, E., Abeni, D. (2007) Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: Accurate and comparable data are needed for effective public health monitoring and interventions. British journal of dermatology, 156 Suppl 3: 1-7
Wetzig, T., Woitek, M., Eichhorn, K., Simon, J.C., Paasch, U. (2010) Surgical Excision of Basal Cell Carcinoma with Complete Margin Control: Outcome at 5-Year Follow-Up. Dermatology, 220(4): 363-369
Wong, V.A., Marshall, J.A., Whitehead, K.J., Williamson, R.M., Sullivan, T.J. (2002) Management of Periocular Basal Cell Carcinoma With Modified En Face Frozen Section Controlled Excision. Ophthalmic Plastic & Reconstructive Surgery, 18(6): 430-435
 

O članku

jezik rada: engleski
vrsta rada: izvorni naučni članak
DOI: 10.5633/amm.2017.0321
objavljen u SCIndeksu: 15.03.2018.
Creative Commons License 4.0